The data on hospital discharges for adnexa and eye diseases in Mexico shows varying trends from 2013 to 2023. The number of discharges was generally higher in the earlier part of the decade, peaking at 26.0 units per hundred thousand persons in 2014. A decline ensued, particularly stark in 2020 during the pandemic, with a significant drop to 6.5 units, marking a year-on-year decrease of 67.66%. Since then, there has been a partial recovery, with 2023 discharges recorded at 17.3 units per hundred thousand persons, representing an 8.13% increase from 2022. However, looking at the five-year compound annual growth rate (CAGR) up to 2023, there is a slight reducing trend of -2.56%. The forecast shows a continued decline with a projected five-year CAGR of -7% by 2028, declining to 11.2 units per hundred thousand persons.
Future trends to watch for include:
- Impact of new healthcare policies and reforms in Mexico on hospital discharges.
- Potential effects of healthcare technology advancements on the rate of adnexa and eye diseases diagnosis and treatment.
- Long-term impacts of the COVID-19 pandemic on healthcare utilization and patient behaviors.
- Changes in population demographics and their potential effect on the prevalence of adnexa and eye diseases.
